Read about how Afrigen Biologics, supported by the WHO, are addressing global vaccine inequity by empowering developing countries with mRNA vaccine production capabilities. Through local manufacturing initiatives and extensive training, Afrigen is fostering sustainable vaccine development to address regional health needs and improve global health security.